Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net earnings/(loss)	$ 321	$ 377
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	332	404
Gain/(Loss) on sale of equity interest in naviHealth	1	0
Impairments and (gain)/loss on disposal of assets, net	1,293	9
Loss on Extinguishment of Debt	10	1
Share-based compensation	42	51
Provision for bad debts	25	35
Change in operating assets and liabilities, net of effects from acquisitions and divestitures:
Increase in trade receivables	(329)	(499)
Increase in inventories	(361)	(1,256)
Increase in accounts payable	1,059	1,861
Other accrued liabilities and operating items, net	(1,842)	504
Net cash provided by operating activities	549	1,487
Cash flows from investing activities:
Acquisition of subsidiaries, net of cash acquired	0	(3)
Additions to property and equipment	(141)	(174)
Purchases of investments	(4)	(18)
Proceeds from investments	22	4
Proceeds from divestitures and disposal of property and equipment and held for sale assets	938	0
Net cash provided by/(used in) investing activities	815	(191)
Cash flows from financing activities:
Reduction of long-term obligations	(592)	(49)
Net proceeds/(tax withholdings) from share-based compensation	(27)	(6)
Dividends on common shares	(289)	(289)
Purchase of treasury shares	(800)	0
Net cash used in financing activities	(1,708)	(344)
Effect of exchange rate changes on cash and equivalents	(11)	14
Cash Reclassified from assets held for sale	109	0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	(246)	966
Cash and equivalents at beginning of period	3,407	2,771
Cash and equivalents at end of period	$ 3,161	$ 3,737